A/P 12.5/45 (Oseni 12.5 mg / 45 mg)
Generic Name: alogliptin/pioglitazone
Pill imprint A/P 12.5/45 has been identified as Oseni 12.5 mg / 45 mg.
Oseni is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 12.5 mg / 45 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- A/P 12.5/45
- 12.5 mg / 45 mg
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
hydroxypropyl cellulose (type l)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 8000
ferric oxide red
Note: Inactive ingredients may vary.
More about Oseni (alogliptin / pioglitazone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.